Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells

Information

  • Research Project
  • 7284842
  • ApplicationId
    7284842
  • Core Project Number
    U01HG004085
  • Full Project Number
    5U01HG004085-02
  • Serial Number
    4085
  • FOA Number
    RFA-HG-05-07
  • Sub Project Id
  • Project Start Date
    9/7/2006 - 17 years ago
  • Project End Date
    8/31/2011 - 12 years ago
  • Program Officer Name
    MARKS, CHERYL L.
  • Budget Start Date
    9/1/2007 - 16 years ago
  • Budget End Date
    8/31/2008 - 15 years ago
  • Fiscal Year
    2007
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/12/2007 - 16 years ago

Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 ES Cells

[unreadable] DESCRIPTION: (provided by applicant) With the sequence of the mouse genome essentially complete, the new long-term goal is to assign function to the genes identified. Knowing the functions for the complete set of genes in a model mammalian organism has obvious biological significance. The value of this information for human health and medicine is in its potential to aid in the discovery of new disease-related genes, to provide the tools needed to create new models for human disease, and to [unreadable] [unreadable] [unreadable] help validate new drug targets. The Knock-Out Mouse Project (KOMP) has set the goal of creating a comprehensive resource of mouse mutations in which every gene in the mouse genome has been knocked out by a null mutation marked with a reporter system. To apply the power of targeted gene modification on the ambitious scale proposed by the KOMP demands significant technological improvements in throughput and capacity. We propose to use our high-throughput and validated VelociGene technology to create a library of 10,000 targeting vectors and a collection of 10,000 mouse ES cell clones, each carrying a definitive null mutation for a unique protein-coding gene. To meet our ambitious production targets, we describe a research plan organized to achieve the following specific aims: [unreadable] 1. Construct a library of BAC-based targeting vectors (BacVecs) designed to create definitive null mutations(in most cases, deletions of the entire coding region) and incorporating a lacZ reporter of high utility for 10,000 mouse protein-coding genes. [unreadable] 2. Using the BacVecs produced by Specific Aim 1, create a collection of C57BL/6 ES cell clones each [unreadable] having a defined null allele and an incorporated reporter for each of 10,000 mouse protein-coding genes,and generate mice from 5% of these ES cell clones (500 mouse lines total) as a test of the collection for germ-line transmission. [unreadable] 3. Create a library of BAC-containing recombination-ready E. coli clones (from Specific Aim 1) that can be used to engineer any desired additional allele (conditionals, replacements, and point mutations)for each of the 10,000 protein coding regions. [unreadable] 4. Provide a database that allows real-time access to all production data and materials linked to the targetgene as the reference point. [unreadable] 5. Devise a computer program that automates the design of null alleles. [unreadable] 6. Robotically automate the preparation and quality control of BACs and BacVecs. [unreadable] 7. Robotically automate the picking of ES cell clones and their expansion, storage and retrieval. [unreadable] 8. Reduce the unit cost of our automated screening by decreasing reagent use and increase throughput and efficiency by improvements in automated data analysis, targeted clone scoring, and database entry. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL HUMAN GENOME RESEARCH INSTITUTE
  • Activity
    U01
  • Administering IC
    HG
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    4614400
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    396
  • Ed Inst. Type
  • Funding ICs
    NCI:485500\NHGRI:1450650\NHLBI:1000000\NICHD:728250\NIDA:200000\NINDS:750000\
  • Funding Mechanism
  • Study Section
    ZHG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    REGENERON PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
    194873139
  • Organization City
    TARRYTOWN
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    10591
  • Organization District
    UNITED STATES